While urokinase plasminogen activator (uPA)-activated PAR1 demonstrably attenuates inflammatory osteoclastogenesis, a process essential for bone destruction in RA [175], the picture with thrombin–PAR1 interaction is more complex. This evidence concerns the gene F2R and rheumatoid arthritis.